Amgen Inc. (NASDAQ:AMGN)’s stock on Wednesday traded at beginning with a price of $173.71 and when day-trade ended the stock finally declined -0.03% to reach at $173.27. Analyst’s mean target price for AMGN is $180.79 while …
This article is published in collaboration with Scutify, where you can find real-time markets and stock commentary from Robert Marcin, Cody Willard and others. Download the Scutify iOS App, the Scutify Android App or visit Scutify.com. …
InvestorPlace - Stock Market News, Stock Advice & Trading TipsAmgen (AMGN) stock was down on Monday after the biotechnology company reported serious adverse events during its Phase 3 Evenity Arch study.The post Amgen, Inc. …
Amgen Inc (NASDAQ:AMGN) has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average ”DividendRank” statistics including a strong 2.1% yield, as well as being …
It has underperformed by 9.16% the S&P500. Ep Wealth Advisors Inc decreased Amgen Inc (AMGN) stake by 11.29% reported in 2016Q4 SEC filing. Institutional investors own 78.84% of the company's stock. The hedge fund held 1.70M …
on the charts AMGN looks constructively positioned through both the near and longer term. As a reminder, certain parts of the stock market are best treated as “themes” as opposed to single-stock stories. Biotechs for example, particularly …
Biotech stock Amgen, Inc. (NASDAQ:AMGN) is no stranger to sliding on drug news. But option bears are getting an extra reward today, as the shares surrender 9.4% to $145.42 -- on track for their worst daily drop since February 2009 -- …
AMGN Stock is Going Nuts The presidential election cycle has been a brutal period for AMGN stock, which fell by some 20% leading up to election night. Analysts feared that a Hillary Clinton administration, which seemed like a sure thing …
Amgen (AMGN) stock toppled in after-hours trading Wednesday after reporting first-quarter sales that missed by $100 million on increased competition for two key drugs in its arsenal — immunosuppressant Enbrel and bone marrow …